chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No pain at injection site.  But 9 hours later I started shivering and was achy. Temperature is 101.3 and holding around 100.3.  very bad headache.   Lukewarm wash cloths for soothing/ cooling.  It's 19 hours do far of fever and headache and achy muscles.   I haven't taken any pain reliever.
PT CONTACTED THE PHARMACY STATING THAT SHE HAD REDNESS/SWELLING IN HER ARM. AFTER A FEW DAYS PT STATED EXPERIENCING A LUMP IN THE INJECTION SITE AREA & WENT TO CLINIC TO BE EXAMINED. PT WAS GIVEN CEPHALEXIN & A MEDROL DOSE PAK & WAS TOLD TO SEE HER PRIMARY CARE PROVIDER WHO GAVE HER PERCOCET FOR THE PAIN SHE WAS FEELING. PT WAS ALSO REFERRED TO AN ORTHOPEDIST WHO SAID THAT SHE HAD FLUID IN THE LUMP AREA. PT IS NOW USING HOT COMPRESSES AND IS FEELING BETTER. MD THINKS ISSUE SHOULD BE RESOLVED BY THE END OF THE WEEK PER PT.
Document Type: History and Physical   Document Subject: History & Physical Note   Performed By: MD on September 02, 2022 18:30   Verified By: MD on September 02, 2022 18:30    Encounter Info: Hospital, Inpatient, 09/02/22 -     * Final Report *     History of Present Illness/Subjective     Patient is a 76-year-old male with a past history of recently diagnosed bronchogenic carcinoma of the right lung present emergency room with increased symptoms of shortness of breath and dyspnea exertion.  Patient began having symptoms of cough congestion and shortness of breath and early August and was started on antibiotic therapy at that time.  This was continued for approximately week to 10 days and then extended by his primary care provider.  He continue his antibiotics almost until about a week ago and had continued improvement in symptoms.  Recent imaging had shown ongoing pneumonitis in this region but improvement.  However this morning he woke up complaining of severe shortness of breath and dyspnea on exertion.  He had a productive cough but it was mostly clear and white in nature.  No hematemesis or hemoptysis.  No symptoms of chest pain or chest discomfort.  No complaints of peripheral edema.  He has not started radiation or chemotherapy as of yet.  He stopped smoking 3 weeks ago.  He is also increasing more somnolent this morning as well.  When EMS arrived his oxygen saturation was 82% on 3 L and he was started on nonrebreather mask prior to coming into the emergency room.  No symptoms of palpitations.  He has been dizzy with arising from recumbency.  Baseline oxygen is 2 to 3 L per nasal cannula.   In the emergency room his blood pressure was 98/61 pulse rate 91 respiratory rate 19 oxygen saturation was 90% on 10 L nonrebreather mask temperature 36.4.   Serology: White count 13,700 with slight left shift hemoglobin 13 hematocrit 40.8 and platelet count of 362,000.  Sodium 138 potassium 4.5 chloride of 102 bicarb 27 BUN 20 creatinine 1.2 and a blood sugar of 215.  Calcium 9.5 troponin of 20 serum lactate 0.9.  Arterial blood gas pH of 7.28/PCO2 60/PO2 73 with O2 sat of 94%.  COVID PCR negative.   CTA of the chest showed no obvious pulmonary embolism.  There is evidence of a right perihilar mass which encases the right lower lobe segmental pulmonary artery with mild narrowing.  Opacification of the right primary bronchus and right lower lobe segmental bronchus which could represent secretions or invasion by neoplasm.  There is a new airspace infiltrate in the right lower lobe posterior basal segment likely postobstructive pneumonia.   Past medical history: COPD, history of tobacco use, chronic renal insufficiency stage III, type 2 diabetes mellitus, coronary artery disease with ischemic cardiomyopathy recent ejection fraction of 40%, paroxysmal atrial flutter, status post ICD, hyperlipidemia, hypertension, anxiety and depression, squamous cell carcinoma of the right lung with known bronchial obstruction
Patient presented to the pharmacy with a type of sore/blister in the exact spot where the vaccine was administered. The patient noticed the sore 1 week after the vaccine was administered and still currently has the sore. It hasn't worsened, is not painful and does not itch.  She did report 2 other spots (had the appearance of a darker purple color) on her hands, but they had a different appearance than the sore on her arm. No other symptoms were reported.
Pt in today with mother. Both stated contacts of Hep A Case. Pt reported not feeling well but stated MD instructed him to get vaccine. Vaccine was given, then as discussion furthered- it was disclosed by family member that the patient was the one with confirmed Hep A. Explained to them, his body is making its own antibodies and vaccine was not needed!
Stood up, felt dizzy, and vision was black. BP 103/49 (pulse 61). O2 sat 100%.
Mother of infant reports w/immunization rxn on 07FEB94; temp 103 & eyes rolled up in head;
About an hour after vaccination developed runny nose, nasal congestion.  Next day had a fever of 100.4F, fatigue and hoarseness.  Hoarseness continued and 3 days later developed a cough.
This spontaneous report was received from a registered nurse referring to a multiple unspecified patients of unknown gender and age. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On an unknown date, the patients were vaccinated with improperly stored doses of VARIVAX (strength, dose, frequency, route of administration were not provided), lots # M043305 with expiration date of 26-OCT-2018; M041080 with expiration date of 06-OCT-2018 and L027287 with expiration date of 21-JUL-2017 for prophylaxis. There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion of 15 degrees Fahrenheit to 46 degrees Fahrenheit (25.8 degrees Fahrenheit) for 60 minutes. Lot # L027287 experienced previous temperature excursion of 15 degrees Fahrenheit to 46 degrees Fahrenheit (32.5 degrees Fahrenheit) for 5 hours, 50 minutes; 15 degrees Fahrenheit to 46 degrees Fahrenheit (40.2 degrees Fahrenheit) for 3 hours, 30 minutes and total time in the range 15 degrees Fahrenheit to 46 degrees Fahrenheit (40.6 degrees Fahrenheit) for 3 hours, 10 minutes. Lots #  M043305 and M041080 experienced previous temperature excursion of 15 degrees Fahrenheit to 46 degrees Fahrenheit (40.6 degrees Fahrenheit) for 3 hours,10 minutes. Data logger was involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1707USA000709: US-009507513-1706USA009296.
Her Husband got the 2nd dose of the Pfizer vaccine and he collapsed and after speaking with the V.A; This is a spontaneous report from a non-contactable consumer. A 50-years-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation The patient medical history was not reported. The patient's concomitant medications were not reported. The patient got the 2nd dose of the vaccine and he collapsed on an unspecified date. The outcome of event was unknown.  No follow-up attempts are possible. No further information is expected.
On 7/25 at 4 pm patient had a fever of 102.4 at which time I gave him 4 ml of acetaminophen. The fever subsided within 30 minutes to 99.0. He had a loss of appetite and would not eat but did take some fluids. (7/25) the fever returned around 9 pm, I gave another 4 ml of acetaminophen. He slept through the night until 8 am the next morning. On 7/26 he had no appetite and only ate 1/3 of what he normally eats. He had two bowel movements throughout the day which were both diarrhea. Around 6 pm the fever returned, I gave him 4 ml of acetaminophen and the fever subsided for the night. On 7/27 patient woke up very fussy and crying non-stop. His fever was at 100.2 so I gave 4 ml of acetaminophen and the fever subsided. He still had no appetite, diarrhea and was very tired. On the night of 7/27 patient woke up every hour crying and slept a total about about 6 hours. I gave him acetaminophen at 9pm and 4 am. 7/28 he was very tired throughout the day and would take naps for about 30 minutes at a time and wake up crying and go back to sleep. He had no bowel movements and still was eating about 1/3 of his normal food intake. He was still taking fluids (milk and water). On 7/28 around 3 pm I noticed a rash on his forehead. The rash was also on his back and stomach. At this time I called the nurse and was told it was a "viral rash". The symptoms and crying continued so I took him to urgent care around 7pm. The doctor informed me he was having an adverse reaction to the vaccine and to continue giving him Tylenol every 4 hours until the rash and fever subsided. As of 7/29 the rash is still present and he still has lack of appetite.
Blisters; Rash that is spreading; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (Blisters) and RASH (Rash that is spreading) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     Concurrent medical conditions included HSV infection. Concomitant products included VALACICLOVIR HYDROCHLORIDE (VALTREX) for HSV infection, CALCIUM, VITAMIN D NOS and ALPRAZOLAM (XANAX) for an unknown indication.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced BLISTER (Blisters) and RASH (Rash that is spreading). At the time of the report, BLISTER (Blisters) and RASH (Rash that is spreading) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       It was reported that the patient has been on and off of Valtrex (valacyclovir) for the past year. Every time the patient stops taking valacyclovir she develops a rash and blisters. The patient was not taking valacyclovir when the COVID-19 vaccine was administered.  Treatment information for the events was not provided.
12/16/2020 around 2300 body aches, followed by chills progressed to rigors, developed a  migraine 6 to 8 hours after fatigue, insomnia, temp was 100.4. Those symptoms progressed and stayed stable for 24 hours until the next night and didn't resolve until the 18th and  late that night I developed lymphadenopathy in left axilla, al nodes very swollen and large. That subsided since then. I took Tylenol and 10mg Rizatriptan  for migraines  and that resolved. **I was in a double blinded study for the AstraZeneca trial and am still unsure whether or not I received the placebo or the actual shot. Nov 30th
This spontaneous report was received from a registered nurse and refers to a 16-year-old patient of unknown gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 18-DEC-2018, the patient was vaccinated with improperly stored dose of RECOMBIVAX HB thimerosal-free, lot # R001530, expiration date 07-NOV-2020 (dose and route of administration were not reported). Administered dose of vaccine experienced the temperature excursion of 31.1 Fahrenheit degrees (F) (below 32 F/ 0 Celsius degrees) (30 cycles) for 35 hours 30 minutes. There were no previous excursions reported. The digital data logger was involved to capture the temperature excursion. No adverse effects were reported. This is one of multiple reports received from the same reporter (It was reported that it was unknown which lot numbers of each specific vaccine were administered to which patient). Sender's Comments: US-009507513-1901USA000128.
The certified medical assistant (CMA) reported that the following improperly stored doses of vaccines were administered to 5 patients on unspecified dates: 5 doses of GARDASIL (dose, route, lot# not reported). No adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
Tinnitus; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Tinnitus) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced TINNITUS (Tinnitus). At the time of the report, TINNITUS (Tinnitus) outcome was unknown. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.
Raised, red patch (size of a quarter) noticed when she awoke the morning after the immunization. At the DTaP injection site. This was itchy & enlarged to a 5-6cm circle - with an outer red ring & central round red, patch. (Looked like a Lyme rash.) Prescribed ATARAX and was almost resolved by 7/24/2012.
At around the 30 hour mark I noticed that my left eyelid had become quite droopy. It appeared to be about half way closed. I didn't seem to have any other symptoms visible on my face but I did end up with random bruising on my right thigh, severe dizziness with nausea, fatigue that lasted about 48 hours and a headache. The fatigue started about two hours after the injection and the rest of the symptoms were the following day.
Achy joints, headache, fever, intense chills, fatigue lasting 24 hours
Broke out with rash a little next day - then faded in a few days then full rash back on Monday Aug 3 arm warm and a little swollen went back to doctor on Aug 4th-put me on antibiotic-cephalexin. Today Aug 12th-rash very faded.
pt recv 2 doses of vax & lab eval on 24JUL96 revealed a negative titer (IgG=0.07);
5 days after administration- heavy uterine bleeding; constipation; severe knee/shoulder joint pain; light sensitivity; dizziness/ light headedness; thigh numbness; pain when prodded on either sides of thighs; harsh headache; This is a spontaneous report from a contactable Other healthcare professional (patient). A 21-year-old female patient received BNT162B2 first dose on 31Dec2020 03:15 PM intramuscularly on left arm at single dose for COVID-19 immunization. Medical history included Depression, Anxiety, Factor V Leiden, Known allergies to Penicillin and Onion sensitivity. Patient is not pregnant. No other vaccine in four weeks. Concomitant medications in two weeks included unspecified medications. "5 days after administration" (also reported as 01Jan2021)- heavy uterine bleeding (resulting with trip to ER), constipation, severe knee/ shoulder joint pain, light sensitivity, dizziness/ light headedness, thigh numbness, pain when prodded on either sides of thighs, harsh headache. No treatment received for the events. Events resulted in ER and physician office visit. No covid prior vaccination. No covid tested post vaccination. The outcome of the events was not recovered. The seriousness was reported as no.   Information on the lot/batch number has been requested.; Sender's Comments: A possible contributory effect of suspect BNT162B2  on reported uterine bleeding cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Day 8 pt noticed increased swelling redness tenderness under left axilla. Office visit day 9. Cellulitis left deltoid + lymphadenopathy 20 sp vaccine. 07/15/02-cellultiis resolving, axillary streaking resolved.
This spontaneous report as received from a Doctor of pharmacy refers to his 11 years old son. On approximately 06-FEB-2013, "a week ago", the patient was vaccinated with a dose of VARIVAX (Merck) (Lot # H017009 expiration date 12-SEP-2014). The pharmacist reported that on approximatley 13-FEB-2013, "after a week" of vaccination, the patient experienced significant skin irritation and swelling. The outcome of significant skin irritation and swelling was unknown. The pharmacist would like to know if there were some reported problems with this particular lot. Additional information has been requested.
Information has been received from a pharmacist via a company representative referring to a patient of unknown age and gender. On an unknown date the patient was vaccinated with ZOSTAVAX (dose, lot# and route were unknown). On an unknown date, the patient developed a rash. The patient was seen by the reporting pharmacist on an unknown date. The outcome of the event was unknown. Additional information is not expected because there was no consent for follow up information.
Pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) in a 34-year-old female patient (gravida 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Pregnancy (Previous Pregnancies). Concurrent medical conditions included Drug allergy (allergic to metaclopramide).   On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was on 10-Dec-2020 and the estimated date of delivery was 16-Sep-2021. On 23-Dec-2020, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  second week of the pregnancy.  On 23-Dec-2020, MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, Pregnancy test: positive (Positive) positive.         No concomitant medication provided by the reporter.  No treatment information provided by the reporter
shingles; This case was reported by a consumer via and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, 1 week after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient had shingles from the 1st shingle vaccine.  Apparently they ran out of the 2nd dose & could not gave the 2nd dose. The patient then got shingles a week after. The patient's physician refused to acknowledge that she had given me the shingles. For tolerance to 2nd dose, refer case US2021AMR203623.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR203623:same reporter, same patient, Different dose
Pt reported flushing, lightheadeness and possible vertigo  approx. 10-15 after getting vaccine. Denied itchiness or SOB Per Pt, vertigo resolved by the time she entered our observation at 10:25a , but still felt slightly warm and lightheaded. Symptoms completely resolved by discharge at 10:40a D/C vitals :BP-125/86 , HR-75, RR- 18, SPO2- 99%
Patient was given the vaccine and within 2 minutes  patient felt dizzy and diaphoretic, impaired vision " saw snow" patient initially put supine, patient had low blood pressure systolic int he 60 patient was taken to observation and bp on arrival was 140/77, HR was 72 and oxygen was 100% on room air.  Patient was put into trendelenberg, he c/o tingling in fingers of his left hand respiration rate was 24, he was  pale, approx 10 minutes later his bp was 134/81, pulse 66, o2 sat 100%. He c/o weakness, he was given water and crackers he was still pale.  Patient was released from the observation area, his girlfriend picked him up and he left the vaccine site . Patient stated that he does get anxious prior to blood draws and injections
Dizziness, palpitation, shortness of breath, sweating, cramps, flushing, heavy chest.
A nurse reported the occurrence of hives and edema in a 23 year old female who was vaccinated with hep A vaccine inactivated for prophylaxis. The subject's medical history, concurrent conditions, and concurrent medications were unknown. On an unspecified date "several years ago," the subject received her third injection of Havrix. Subsequently, she experienced hives and edema. The events resolved after an unspecified period of time.
Same day of receiving the vaccination woke up with chills, fever, nauseous, tingling feeling in the index finger.  Next day body was in pain, no appetite, dehydration, soreness at injection site.
Fever to 102 for 1-2 days, malaise, nausea/vomit 1 day, headache, arm red & swollen.
Administer Pt. Tdap/MCV/HPV. A couple of minutes after pt. started feeling dizziness/swollen lips/swollen eyes/rash/hives and stated she couldn't see or hear. Gave pt. 10 ml of BENADRYL called EMS/started Neb Tx at 5:45, Oxygen at 5:50. EMS arrived at 5:55 took over pt. care.
On 12/10 around 3pm she had a 2 vaccines. Fluzone High Dose 180 mcg/0.5mL and Varicella-zoster 50 mcg/o.5mL. At 9:20pm, after going out to a movie,  she suffered sudden cardiac arrest. 911 was immediately called. She never regained consciousness and was taken off of life support on 12/14. I asked multiple doctors why they thought her heart stopped and none of them knew why. I explained to them that I (her daughter) have a genetic condition called MCAS which has been linked to Kounis Syndrome which can cause coronary vasospasms. I was told it was too rare to consider. A couple of weeks later I found her vaccination papers. I called her doctor's office to let them know. The woman on the phone pulled up her name. As she was reading, she said that they hadn't been informed and thanks for letting them know and suddenly her entire tone changed and she said I'd have to talk to someone else and hung up. I believe she was trying to transfer me but I can't help but wonder if she was having a small reaction earlier that day in the office and they let her go.
Reported Symptoms:  10018767:GUILLAIN-BARRE SYNDROME;    Narrative:  Per  December 12. 2022 Nurse Practitioner's documentation  A 94yo male who presented for tele visit to establish care with Geriatrics and with PMH of Cochlear Implant, Alzheimer's Dementia, OA of Knee and Guillain Barre Syndrome (from flu shot)  No other
Rash on the site of injection spreading around the arm, mild nausea, lightheadedness, malaise, dizziness.
TDAP given instead of 4th DTAP (provider, mother made aware), no adverse effect noted, no repeat dose necessary
Moderna COVID 19 Vaccine Bivalent EUA Fast heartbeat, nausea, dizziness, sudden cough and feeling of choking, runny nose, red and teary eyes, sudden diaphoresis, general weakness
Patient states that 2 days after receiving the vaccine she developed multiple red splotches on her arm. The next day she experienced swelling in the arm along with the red splotches.
Noticeably rapid heart rate for 20 minutes right after shot.  Sat still in waiting room until it subsided.
Vesicular rash on trunk, arms and legs consistent with varicella seen by Allergy & Immunology. Tx'd with Acycleryn for 5 days.
This case was reported by a physician via call center representative and described the occurrence of papular rash in a 65-year-old male patient who received SHINGRIX for prophylaxis. On 28th June 2018, the patient received SHINGRIX. On 9th July 2018, 11 days after receiving SHINGRIX, the patient experienced papular rash. On an unknown date, the outcome of the papular rash was not recovered/not resolved. It was unknown if the reporter considered the papular rash to be related to SHINGRIX. Additional details were reported as follows: On the day of reporting, the patient visited the physician's office with a 3 day history of papules on the top and bottom of his hands and feet, under his arms and around his knees.